Glimepiride 3mg + Metformin 500mg Tablet in PCD pharma franchise in Hyderabad

Glimepiride 3mg + Metformin 500mg Tablet in pharmaceutical manufacturing company in Mumbai

Glimepiride 3mg + Metformin 500mg Tablet in antidiabetic pharma franchise in Pune

Glimepiride 3mg + Metformin 500mg Tablet in pharma suppliers in Delhi

Glimepiride 3mg + Metformin 500mg Tablet in pharma export companies in Kolkata
Glimepiride 3mg + Metformin 500mg Tablet in pharma franchise opportunities in Bengaluru

Metfoam G3 Tablet

Composition : Glimepiride I.P. 3mg + Metformin Hydrochloride (S.R.) I.P. 500mg Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹1/-

Please Contact For Best Price

Metfoam G3 Tablet is a combination of Glimepiride 3mg and Metformin Hydrochloride 500mg in a sustained-release bi-layered formulation. It is designed to offer dual benefits in the management of type 2 diabetes mellitus by improving glycemic control. Glimepiride, a sulfonylurea, stimulates insulin secretion from the pancreas, while Metformin enhances insulin sensitivity and reduces hepatic glucose production. The bi-layered design ensures optimal release for prolonged efficacy.

Read More

About the Product

Metfoam G3 Tablet is a combination of Glimepiride 3mg and Metformin Hydrochloride 500mg in a sustained-release bi-layered formulation. It is designed to offer dual benefits in the management of type 2 diabetes mellitus by improving glycemic control. Glimepiride, a sulfonylurea, stimulates insulin secretion from the pancreas, while Metformin enhances insulin sensitivity and reduces hepatic glucose production. The bi-layered design ensures optimal release for prolonged efficacy.

May cause hypoglycemia, gastrointestinal discomfort, nausea, metallic taste, or weight gain. Metformin may rarely lead to lactic acidosis, a serious but uncommon complication.

Indicated for the management of type 2 diabetes mellitus in adults, especially in patients who require both insulin secretion stimulation and improved insulin sensitivity to control blood glucose levels.

Should be taken with meals to reduce the risk of gastrointestinal side effects. Regular blood sugar monitoring is essential. Not for use in type 1 diabetes or diabetic ketoacidosis. Use with caution in patients with renal or hepatic impairment.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch